Medium term follow-up after percutaneous pulmonary valve replacement with the Melody® valve

Data on long term function of the Melody valve are scarce. Patients and methods: single institution; results of percutaneous pulmonary valve implantation (PPVI) from 2006 to 2014. The function of the valved conduit was analyzed by Doppler echocardiography. Annual Chest X-ray after implant and perman...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cardiology. Heart & vasculature Vol. 7; no. C; pp. 92 - 97
Main Authors Cools, Bjorn, Budts, Werner, Heying, Ruth, Boshoff, Derize, Eyskens, Benedicte, Frerich, Stefan, Troost, Els, Gewillig, Marc
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.06.2015
Elsevier
Subjects
Online AccessGet full text
ISSN2352-9067
2352-9067
DOI10.1016/j.ijcha.2015.02.014

Cover

More Information
Summary:Data on long term function of the Melody valve are scarce. Patients and methods: single institution; results of percutaneous pulmonary valve implantation (PPVI) from 2006 to 2014. The function of the valved conduit was analyzed by Doppler echocardiography. Annual Chest X-ray after implant and permanent screening for events (e.g. Endocarditis). 112 Melody valves were implanted in 111 patients; mean age 19.3years (4.5–81.6). No pre-stenting of the RVOT was performed (n=4) at first. In the next 107 patients pre-stenting was always performed. In 82 patients 1 pre-stent, 18 patients 2, in 6 patients 3 stents and 1 patient 4 stents were used. The Melody stent was dilated up to 24mm (n=4), 22mm (n=72), 20mm (n=28) and 18mm (n=6). When stenotic, the Doppler gradient reduced from 67.0mmHg (SD 13.9) to 18.9mmHg (SD 10.4) (p<0.001); pulmonary regurgitation (PR) was reduced from median 3.5/4 (range 0–4/4) to none or trivial (p<0.001). There was no significant change in RVOT peak velocity at 5years (p=0.122) nor PR (p=0.835). Type 1 stent fractures were observed in 1/4 non-pre-stented patients and in 5/107 pre-stented (p<0.05). Endocarditis occurred in 8/112 valves; freedom of endocarditis was 85% at 5years. In 2 patients early surgical replacement was necessary. Six were sterilized with antibiotic treatment; 2 patients required re-stenting and re-PPVI due to residual gradient. Adequate pre-stenting of the RVOT before PPVI nearly abolishes or delays stent fracture. Cusp function is well preserved in mid-term follow-up; endocarditis is a threat.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2352-9067
2352-9067
DOI:10.1016/j.ijcha.2015.02.014